The next evolution of body contouring has arrived.
alloClae is the first structural adipose tissue designed for aesthetic body procedures, providing cushioning, volume and support. It can help you differentiate your practice and deliver uniquely outstanding results for your patients.
alloClae is composed of intact adipocytes and ECM1
ECM with naturally occurring factors to support lasting results
Intact adipocyte membrane and honeycomb structure to provide volume
ALLOCLAE 250X MAGNIFICATION
Transformative solution.
Supported by science.
alloClae is sterilized donor derived adipose tissue
A groundbreaking approach to processing adipose tissue:
- Retains the innate 3D honeycomb structure of the adipocytes to provide immediate volume at the application site
- Maintains extracellular matrix with naturally occurring factors, proteins and collagens for lasting results
- Terminally sterilizes the tissue to a sterility assurance level (SAL) of 10-6
- Reduces free oil fraction to <2%; minimizing the risk of oil cysts
- Minimizes DNA content, reducing the immunogenic response
REFERENCES: 1. Fanniel et al. Bioengineering (Basel). 2025; 12(6):612.
IMPORTANT SAFETY INFORMATION: alloClae is intended to be applied subcutaneously in localized areas of the body to provide cushioning and support to the patient's body where adipose tissue naturally exists. alloClae does not contain viable cells, and has no systemic effect, and is not dependent upon the metabolic activity of living cells for its primary function. This allograft is intended for single patient use only. Human tissue shall not be offered or dispensed for veterinary use. alloClae should not be used on patients with severe allergen sensitivities, a history of anaphylaxis, or in the presence of active infection. Like all procedures of this type there is a possibility of complications, although not everyone experiences them. Those potential complications include cystic or nodule formations, pain or infection, hematoma, anaphylaxis or other allergic or immune responses, or discoloration of the skin at the procedure site.
